Xiaojun CHANG, Caixia YAN, Binghong ZHANG, Jijie WANG, Xiaolian YI

Intestinal trefoil factor increased the Bcl-2 level in a necrotizingenterocolitis neonate rat model

Background/aim: The aim of this study was to investigate the therapeutic effect of intestinal trefoil factor (ITF) on necrotizing enterocolitis (NEC) by observing the pathological changes and detecting the protein level differences in Caspase-3, Bax, and Bcl-2 in an NEC neonate rat model. Materials and methods: A Wistar rat model of NEC was established and 30 one-day-old neonate Wistar rats were randomly divided into three groups including a normal control (group A), NEC rats treated with 0.2 ml physiological saline through intraperitoneal (i.p.) injection (group B), and NEC rats treated with 0.2 mg ITF by i.p injection (group C). Results: Compared with group B, there were statistically significant differences in Caspase-3, Bax, and Bcl-2 levels in groups A and C (P < 0.05). Moreover, there was a significant difference in the Bcl-2 level between groups A and B (P < 0.05). Conclusion: ITF alleviated injury of the intestinal tract in neonate rats with NEC and this mechanism was possibly related to a reduction in the expression of Caspase-3 and Bax and the increase in Bcl-2 expression.

PDF

___

1. Markel TA, Crisostomo PR, Wairiuko GM, Pitcher J, Tsai BM, Meldrum DR. Cytokines in necrotizing enterocolitis. Shock 2006; 25: 329-337.
2. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011; 364: 255-264.
3. Sharma R, Hudak ML. A clinical perspective of necrotizing enterocolitis: past, present, and future. Clin Perinatol 2013; 40: 27-51.
4. Neal MD, Leaphart C, Levy R, Prince J, Billiar TR, Watkins S, Li J, Cetin S, Ford H, Schreiber A et al. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 2006; 176: 3070-3079.
5. Ayala A, Song GY, Chung CS, Redmond KM, Chaudry IH. Immune depression in polymicrobial sepsis: the role of necrotic (injured) tissue and endotoxin. Crit Care Med 2000; 28: 2949-2955.
6. Moss RL, Kalish LA, Duggan C, Johnston P, Brandt ML, Dunn JC, Ehrenkranz RA, Jaksic T, Nobuhara K, Simpson BJ et al. Clinical parameters do not adequately predict outcome in necrotizing enterocolitis: a multi-institutional study. J Perinatol 2008; 28: 665-674.
7. Upperman JS, Camerini V, Lugo B, Yotov I, Sullivan J, Rubin J, Clermont G, Zamora R, Ermentrout GB, Ford HR et al. Mathematical modeling in necrotizing enterocolitis-a new look at an ongoing problem. J Pediatr Surg 2007; 42: 445-453.
8. Ibáñez V, Couselo M, Marijuán V, Vila JJ, García-Sala C. Could clinical scores guide the surgical treatment of necrotizing enterocolitis? Pediatr Surg Int 2012; 28: 271-276.
9. Ng EW, Poon TC, Lam HS, Cheung HM, Ma TP, Chan KY, Wong RP, Leung KT, Lam MM, Li K et al. Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Ann Surg 2013; 258: 1111-1118.
10. Shi L, Zhang BH, Yu HG, Yu JP, Xi JL. Intestinal trefoil factor in treatment of neonatal necrotizing enterocolitis in the rat model. J Perinat Med 2007; 35: 443-446.
11. Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez-Crussi F. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2003; 6: 6-23.
12. Suemori S, Lynch-Devaney K, Podolsky DK. Identification and characterization of rat intestinal trefoil factor: tissue- and cellspecific member of the trefoil protein family. P Natl Acad Sci USA 1991; 88: 11017-11021.
13. Madsen J, Nielsen O, Tornøe I, Thim L, Holmskov U. Tissue localization of human trefoil factors 1, 2, and 3. J Histochem Cytochem 2007; 55: 505-513.
14. Zhang BH, Yu HG, Sheng ZX, Luo HS, Yu JP. The therapeutic effect of recombinant human trefoil factor 3 on hypoxiainduced necrotizing enterocolitis in immature rat. Regul Peptides 2003; 116: 53-60.
15. Hsueh W, De Plaen IG, Caplan MS, Qu XW, Tan XD, GonzalezCrussi F. Neonatal necrotizing enterocolitis: clinical aspects, experimental models and pathogenesis. World J Pediatr 2007; 3: 17-29.
16. Barrera GJ, Sanchez G, Gonzalez JE. Trefoil factor 3 isolated from human breast milk downregulates cytokines (IL8 and IL6) and promotes human beta defensin (hBD2 and hBD4) expression in intestinal epithelial cells HT-29. Bosnian J Basic Med 2012; 12: 256-264.
17. Shi L, Zhou PH, Xi JL, Yu HG, Zhang BH. Recombinant human trefoil factor 3 ameliorates bowel injury: its anti-inflammatory effect on experimental necrotizing enterocolitis. Int J Pept 2014; 2014: 634135.
18. Xu LF, Teng X, Guo J, Sun M. Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor. Inflammation 2012; 35: 308-315.
19. Sun Y, Zhu Y, Wang L, Mao X, Peng X, Peng Y. Recombinant adenovirus-mediated intestinal trefoil factor gene therapy for burn-induced intestinal mucosal injury. PLoS One 2013; 8: e62429.
20. Mazumder S, Plesca D, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol 2008; 414: 13-21.
21. Youle RJ, Strasser A. The Bcl-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Bio 2008; 9: 47-59.
22. Chan MW, Chan VY, Leung WK, Chan KK, To KF, Sung JJ, Chan FK. Anti-sense trefoil factor family-3 (intestinal trefoil factor) inhibits cell growth andinduces chemosensitivity to adriamycin in human gastric cancer cells. Life Sci 2005; 76: 2581-2592.
23. Taupin DR, Kinoshita K, Podolsky DK. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. P Natl Acad Sci USA 2000; 97: 799-804.
24. Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Bio 2003; 4: 721-732.
25. Chipuk JE, Green DR. How do BCL-2 proteins induce mitochondrial outermembrane permeabilization? Trends Cell Biol 2008; 18: 157-164.
26. Danial NN. BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res 2007; 13: 7254-7263.